Analysis of publicly available datasets for NQO1 expression in surgical specimens showed significantly lower expression in metastatic tumors (liver, lymph node, lung, adrenal; (P < 0.0001 with unpaired t-test) compared with primary prostate tumors (Fig. 2a)24. Here, NQO1 is linked to prostate neoplasm.